Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : LOM Medical International Inc.(LOMM)Nasdaq otc. -- Ignore unavailable to you. Want to Upgrade?

To: Martin who wrote (41)	2/13/2000 2:33:00 PM
From: bcjt	Read Replies (1) \| Respond to of 97

L.O.M. Medical International Inc. Newsletter & Update Volume 4, Issue 1 March, 2000 -------------------------------------------------------------------------------- An L.O.M. Corporate Update Funding L.O.M. Medical now has a funding commitment for it's offering memorandum @ $5.00 USD, subject only to the securities commission clearance of our 10 SB filing which was done on January 18, 2000. Once securities issues us a letter of approval, we plan to commence trading immediately. All of our shareholders will be notified 7 days prior to the commencement of trading. lomm.com . Product Marketing and Other Events L.O.M. Medical International Inc., has received inquiries from many companies from all over the world concerning the licensing and/or distribution of our Retractable Safety Syringe. We are currently dealing with an Austrailian company for the distribution, licensing, and manufacturing of our syringe in both Australia and New Zealand. Other Events: Henry Galvin, our Irish Consultant, is presently in Ireland and will be back in Canada next week with his report. John Klippenstein has recently met with Stepp & Beauchamp in Los Angelos and has dealt with some security matters. Our Lawyer, Thomas Stepp has scheduled a meeting with Pacific Acquisition Group's CEO, Mr. James Hock Jr. . Mr. Hock has a background in corporate planning and financial strategies, as well as acquisition funding for various corporations. He was also a senior analyst for Smith Barney of New York for 22 years prior to opening his own office in L.A. 8 years ago. Mr. Hock will be involved in our long-term financial planning. bcjt